| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.2 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.18 | 0.2 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.37 | 0.2 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |